[Drugs against symptomatic, benign prostatic hyperplasia].
作者信息
Johansen Truls E Bjerklund
机构信息
Urologisk seksjon Kirurgisk klinikk Sykehuset Telemark 3906 Porsgrunn.
出版信息
Tidsskr Nor Laegeforen. 2002 Oct 30;122(26):2544-5.
PMID:12522881
Abstract
摘要
相似文献
1
[Drugs against symptomatic, benign prostatic hyperplasia].
Tidsskr Nor Laegeforen. 2002 Oct 30;122(26):2544-5.
2
The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group.
N Engl J Med. 1996 Aug 22;335(8):533-9. doi: 10.1056/NEJM199608223350801.
3
The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia.
N Engl J Med. 2003 Dec 18;349(25):2387-98. doi: 10.1056/NEJMoa030656.
4
Benign prostatic hyperplasia (BPH).
Harv Mens Health Watch. 2006 Aug;11(1):3.
5
Medical management of benign prostatic hyperplasia--are two drugs better than one?
N Engl J Med. 2003 Dec 18;349(25):2449-51. doi: 10.1056/NEJMe038154.
6
[Therapy of benign prostatic hyperplasia: terazosin or finasteride?].
Praxis (Bern 1994). 1997 Aug 20;86(34):1305-6.
7
Treatment of benign prostatic hyperplasia.
N Engl J Med. 1996 Aug 22;335(8):586-7. doi: 10.1056/NEJM199608223350809.
8
Finasteride in benign prostatic hyperplasia.
N Engl J Med. 2004 Mar 25;350(13):1359-61; author reply 1359-61.
9
Finasteride in benign prostatic hyperplasia.
N Engl J Med. 2004 Mar 25;350(13):1359-61; author reply 1359-61. doi: 10.1056/NEJMc045013.
10
Advances in the medical management of benign prostatic hyperplasia.
CMAJ. 2007 Jun 19;176(13):1850-1. doi: 10.1503/cmaj.060439.
Zotero 插件